Pre-earnings options volume in Protagonist Therapeutics is 1.2x normal with calls leading puts 10:9. Implied volatility suggests the market is anticipating a move near 4.6%, or $1.12, after results are released. Median move over the past eight quarters is 1.9%.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PTGX:
- Protagonist Therapeutics options imply 7.3% move in share price post-earnings
- Protagonist Therapeutics Surges 52% after Successful Phase 2 Trial
- Protagonist Therapeutics reports ‘positive’ results from FRONTIER 1 Phase 2b
- Protagonist Therapeutics participates in a conf call hosted by Piper Sandler
- J&J conference call comments ‘a good sign’ for Protagonist, says JMP Securities
